CareDx Current Ratio 2013-2025 | CDNA

CareDx current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CareDx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.35B $0.09B 4.11
2024-12-31 $0.35B $0.09B 3.94
2024-09-30 $0.33B $0.08B 4.10
2024-06-30 $0.32B $0.08B 4.09
2024-03-31 $0.30B $0.07B 4.32
2023-12-31 $0.31B $0.08B 4.02
2023-09-30 $0.35B $0.07B 4.75
2023-06-30 $0.36B $0.07B 4.84
2023-03-31 $0.37B $0.07B 5.17
2022-12-31 $0.39B $0.08B 5.11
2022-09-30 $0.39B $0.07B 5.52
2022-06-30 $0.40B $0.08B 5.15
2022-03-31 $0.41B $0.07B 6.15
2021-12-31 $0.43B $0.08B 5.61
2021-09-30 $0.45B $0.07B 6.38
2021-06-30 $0.44B $0.06B 7.84
2021-03-31 $0.44B $0.05B 9.59
2020-12-31 $0.27B $0.07B 3.95
2020-09-30 $0.26B $0.06B 4.14
2020-06-30 $0.25B $0.06B 4.42
2020-03-31 $0.07B $0.03B 2.33
2019-12-31 $0.07B $0.04B 2.07
2019-09-30 $0.07B $0.03B 2.20
2019-06-30 $0.07B $0.03B 2.39
2019-03-31 $0.08B $0.02B 4.74
2018-12-31 $0.08B $0.02B 4.16
2018-09-30 $0.04B $0.02B 2.65
2018-06-30 $0.03B $0.01B 2.16
2018-03-31 $0.03B $0.01B 2.43
2017-12-31 $0.03B $0.04B 0.62
2017-09-30 $0.02B $0.03B 0.55
2017-06-30 $0.02B $0.05B 0.37
2017-03-31 $0.02B $0.05B 0.44
2016-12-31 $0.03B $0.04B 0.65
2016-09-30 $0.04B $0.04B 0.89
2016-06-30 $0.03B $0.04B 0.85
2016-03-31 $0.03B $0.01B 1.94
2015-12-31 $0.03B $0.01B 3.39
2015-09-30 $0.04B $0.01B 3.63
2015-06-30 $0.04B $0.01B 4.85
2015-03-31 $0.04B $0.01B 6.74
2014-12-31 $0.04B $0.01B 3.62
2014-09-30 $0.04B $0.01B 3.78
2014-06-30 $0.01B $0.02B 0.64
2014-03-31 $0.01B $0.01B 0.90
2013-12-31 $0.01B $0.01B 1.08
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.01B 1.18
Sector Industry Market Cap Revenue
Medical Medical Services $1.087B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.092B 26.27
CVS Health (CVS) United States $84.870B 10.55
Elevance Health (ELV) United States $84.768B 10.94
Cencora (COR) United States $56.829B 19.77
Natera (NTRA) United States $22.878B 0.00
DiDi Global (DIDIY) China $22.356B 23.75
Labcorp Holdings (LH) United States $21.716B 17.61
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.887B 0.00
Solventum (SOLV) United States $12.588B 13.33
CochLear (CHEOY) Australia $12.104B 0.00
ICON (ICLR) Ireland $11.456B 10.65
Revvity (RVTY) United States $11.099B 19.10
Doximity (DOCS) United States $10.990B 50.88
Viatris (VTRS) United States $10.281B 3.53
Avantor (AVTR) United States $8.961B 13.02
HealthEquity (HQY) United States $8.648B 37.88
Medpace Holdings (MEDP) United States $8.563B 22.74
Sonic Healthcare (SKHHY) Australia $8.268B 0.00
Charles River Laboratories (CRL) United States $7.124B 13.96
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.096B 24.12
BrightSpring Health Services (BTSG) United States $3.753B 34.44
Sotera Health (SHC) United States $3.108B 17.66
Alignment Healthcare (ALHC) United States $2.883B 0.00
Concentras Parent (CON) United States $2.704B 15.63
Surgery Partners (SGRY) United States $2.605B 33.88
Organon (OGN) United States $2.561B 2.72
PACS (PACS) United States $1.882B 0.00
Progyny (PGNY) United States $1.846B 40.62
Premier (PINC) United States $1.832B 13.91
GeneDx Holdings (WGS) United States $1.827B 70.37
Ardent Health (ARDT) United States $1.818B 7.75
GoodRx Holdings (GDRX) United States $1.568B 31.36
Teladoc Health (TDOC) United States $1.242B 0.00
Pediatrix Medical (MD) United States $1.152B 8.76
Establishment Labs Holdings (ESTA) $1.082B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.869B 0.00
AMN Healthcare Services Inc (AMN) United States $0.842B 7.88
QDM (QDMI) Hong Kong, SAR China $0.758B 0.00
Nutex Health (NUTX) United States $0.642B 9.71
LifeMD (LFMD) United States $0.617B 0.00
Embecta (EMBC) United States $0.575B 3.87
InnovAge Holding (INNV) United States $0.505B 0.00
Enhabit (EHAB) United States $0.485B 39.92
Auna S.A (AUNA) Luxembourg $0.472B 10.63
SBC Medicals (SBC) United States $0.469B 0.00
Sonida Senior Living (SNDA) United States $0.454B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.419B 0.00
Omada Health (OMDA) $0.390B 0.00
Performant Healthcare (PHLT) United States $0.261B 0.00
Oncology Institute (TOI) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.115B 0.00
So-Young (SY) China $0.104B 0.00
OncoCyte (OCX) United States $0.092B 0.00
KindlyMD (NAKA) United States $0.089B 0.00
Sera Prognostics (SERA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.052B 0.00
Basel Medical Group (BMGL) Singapore $0.050B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00